REPORT ID 4823

EMEA (Europe, Middle East and Africa) Ocular Drug Delivery Market Report 2017

Publish Date
19-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the EMEA Ocular Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Ocular Drug Delivery for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Ocular Drug Delivery market competition by top manufacturers/players, with Ocular Drug Delivery sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
    OCULAR THERAPEUTIX, INC
    Alimera Sciences
    Allergan, Plc
    EyeGate Pharma
    Valeant Pharmaceuticals International, Inc
    Envisia Therapeutics
    Clearside Biomedical
    Graybug Vision Inc
    Taiwan Liposome Company
    Santen Pharmaceutical Co., Ltd

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    By Technology
        Ocular Insert
        Iontophoresis
        Intraocular Implants
        In Situ Gel & Punctal Plugs
        Others
    By Form
        Solution
        Suspension
        Emulsion
        Liposomes & Nanoparticles
        Ointment

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Ambulatory Surgical Centers
    Ophthalmic Clinics
    Homecare Settings

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Ocular Drug Delivery Market Report 2017
1 Ocular Drug Delivery Overview
    1.1 Product Overview and Scope of Ocular Drug Delivery
    1.2 Classification of Ocular Drug Delivery
        1.2.1 EMEA Ocular Drug Delivery Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Ocular Drug Delivery Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Ocular Insert
        1.2.4 Iontophoresis
        1.2.5 Intraocular Implants
        1.2.6 In Situ Gel & Punctal Plugs
        1.2.7 Others
    1.3 EMEA Ocular Drug Delivery Market by Application/End Users
        1.3.1 EMEA Ocular Drug Delivery Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Ophthalmic Clinics
        1.3.5 Homecare Settings
    1.4 EMEA Ocular Drug Delivery Market by Region
        1.4.1 EMEA Ocular Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Ocular Drug Delivery (2012-2022)
        1.5.1 EMEA Ocular Drug Delivery Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Ocular Drug Delivery Revenue and Growth Rate (2012-2022)

2 EMEA Ocular Drug Delivery Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Ocular Drug Delivery Market Competition by Players/Manufacturers
        2.1.1 EMEA Ocular Drug Delivery Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Ocular Drug Delivery Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Ocular Drug Delivery Sale Price by Players (2012-2017)
    2.2 EMEA Ocular Drug Delivery (Volume and Value) by Type/Product Category
        2.2.1 EMEA Ocular Drug Delivery Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Ocular Drug Delivery Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Ocular Drug Delivery Sale Price by Type (2012-2017)
    2.3 EMEA Ocular Drug Delivery (Volume) by Application
    2.4 EMEA Ocular Drug Delivery (Volume and Value) by Region
        2.4.1 EMEA Ocular Drug Delivery Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Ocular Drug Delivery Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Ocular Drug Delivery Sales Price by Region (2012-2017)

3 Europe Ocular Drug Delivery (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Ocular Drug Delivery Sales and Value (2012-2017)
        3.1.1 Europe Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
    3.2 Europe Ocular Drug Delivery Sales and Market Share by Type
    3.3 Europe Ocular Drug Delivery Sales and Market Share by Application
    3.4 Europe Ocular Drug Delivery Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Ocular Drug Delivery Sales Volume by Countries (2012-2017)
        3.4.2 Europe Ocular Drug Delivery Revenue by Countries (2012-2017)
        3.4.3 Germany Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        3.4.4 France Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        3.4.5 UK Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        3.4.6 Russia Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        3.4.7 Italy Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Ocular Drug Delivery Sales and Growth Rate (2012-2017)

4 Middle East Ocular Drug Delivery (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Ocular Drug Delivery Sales and Value (2012-2017)
        4.1.1 Middle East Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
    4.2 Middle East Ocular Drug Delivery Sales and Market Share by Type
    4.3 Middle East Ocular Drug Delivery Sales and Market Share by Application
    4.4 Middle East Ocular Drug Delivery Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Ocular Drug Delivery Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Ocular Drug Delivery Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        4.4.4 Israel Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        4.4.5 UAE Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        4.4.6 Iran Ocular Drug Delivery Sales and Growth Rate (2012-2017)

5 Africa Ocular Drug Delivery (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Ocular Drug Delivery Sales and Value (2012-2017)
        5.1.1 Africa Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
    5.2 Africa Ocular Drug Delivery Sales and Market Share by Type
    5.3 Africa Ocular Drug Delivery Sales and Market Share by Application
    5.4 Africa Ocular Drug Delivery Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Ocular Drug Delivery Sales Volume by Countries (2012-2017)
        5.4.2 Africa Ocular Drug Delivery Revenue by Countries (2012-2017)
        5.4.3 South Africa Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Ocular Drug Delivery Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Ocular Drug Delivery Sales and Growth Rate (2012-2017)

6 EMEA Ocular Drug Delivery Manufacturers/Players Profiles and Sales Data
    6.1 OCULAR THERAPEUTIX, INC
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Ocular Drug Delivery Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Alimera Sciences
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Ocular Drug Delivery Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Allergan, Plc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Ocular Drug Delivery Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 EyeGate Pharma
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Ocular Drug Delivery Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Valeant Pharmaceuticals International, Inc
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Ocular Drug Delivery Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Envisia Therapeutics
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Ocular Drug Delivery Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Clearside Biomedical
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Ocular Drug Delivery Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Graybug Vision Inc
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Ocular Drug Delivery Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Taiwan Liposome Company
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Ocular Drug Delivery Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Santen Pharmaceutical Co., Ltd
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Ocular Drug Delivery Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Ocular Drug Delivery Manufacturing Cost Analysis
    7.1 Ocular Drug Delivery Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Ocular Drug Delivery

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Ocular Drug Delivery Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Ocular Drug Delivery Market Forecast (2017-2022)
    11.1 EMEA Ocular Drug Delivery Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Ocular Drug Delivery Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Ocular Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Ocular Drug Delivery Price and Trend Forecast (2017-2022)
    11.2 EMEA Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Ocular Drug Delivery Sales Forecast by Type (2017-2022)
    11.7 EMEA Ocular Drug Delivery Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer